InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,447.85
(
-0.31%
)
US TECH 100
19,007.60
(
-1.04%
)
Dow Jones
39,410.87
(
0.67%
)
Brent Oil
85.28
(
1.49%
)
Bitcoin
59,511.28
(
-5.78%
)
Post# of 252331
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 833
Posts 119907
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: dewophile post# 224478

Friday, 04/05/2019 10:57:02 AM

Friday, April 05, 2019 10:57:02 AM

Post# of 252331
Nitpick—Sovaldi was actually the third HCV drug discovered by Pharmasset; the first was R7138 (licensed to Roche) and the second was PSI-7851. This is a nitpick because Sovaldi (a/k/a PSI-7977) was a single-isomer tweak of PSI-7851.

PSI-7851 press release from 5/19/08:
http://www.natap.org/2008/HCV/051908_02.htm

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up